{"id":"NCT03677934","sponsor":"Hoffmann-La Roche","briefTitle":"A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration","officialTitle":"Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-Comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-09-12","primaryCompletion":"2020-05-22","completion":"2021-06-09","firstPosted":"2018-09-19","resultsPosted":"2022-03-25","lastUpdate":"2022-10-04"},"enrollment":415,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Neovascular Age-Related Macular Degeneration"],"interventions":[{"type":"DRUG","name":"PDS Implant filled with 100 mg/mL Ranibizumab","otherNames":[]},{"type":"DRUG","name":"Intravitreal Injections of 10 mg/mL Ranibizumab","otherNames":[]}],"arms":[{"label":"PDS Implant Arm","type":"EXPERIMENTAL"},{"label":"Intravitreal Arm","type":"ACTIVE_COMPARATOR"}],"summary":"Study GR40548 is a Phase III, randomized, multicenter, open-label (visual assessor \\[VA\\]-masked), active-comparator study designed to assess the efficacy, safety, and pharmacokinetics (PK) of 100mg/ml delivered via the Port Delivery System with ranibizumab (PDS) compared with ranibizumab intravitreal injections at 0.5 mg (10 mg/mL) in participants with neovascular age-related macular degeneration (nAMD).","primaryOutcome":{"measure":"Change From Baseline in Best-Corrected Visual Acuity (BCVA) Score at the Average of Week 36 and Week 40, as Assessed Using the ETDRS Visual Acuity Chart at a Starting Distance of 4 Meters","timeFrame":"Baseline, and the average of Week 36 and Week 40","effectByArm":[{"arm":"PDS Implant Arm","deltaMin":0.2,"sd":null},{"arm":"Intravitreal Arm","deltaMin":0.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":18},"locations":{"siteCount":77,"countries":["United States"]},"refs":{"pmids":["39447871","39209113","39154860","38914294","35708706","35589078","33863399"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":39,"n":167},"commonTop":["Conjunctival haemorrhage","Conjunctival hyperaemia","Iritis","Neovascular age-related macular degeneration","Eye pain"]}}